Oct 17 2026 | By: Burzynski Clinic
Before joining a cancer clinical trial, ask what the study is designed to learn, who is eligible, what treatment is being tested, what is known and unknown, how safety is monitored, which costs may apply, and what alternatives exist. Participation is voluntary, and informed consent should be an ongoing discussion rather than a one-time signature.
This article is educational and does not provide individualized medical advice. A qualified clinician should interpret records, tests, risks, and treatment options for the specific patient.
Some trials study safety and dose. Others compare effectiveness, study side effects, test ways to prevent cancer, or improve symptom management. Ask what the specific trial is designed to answer and whether its main objective matches the patient's goals.
Eligibility criteria may involve cancer type, stage, prior treatment, biomarkers, age, medical history, and current health. The National Cancer Institute recommends gathering detailed cancer information before searching because eligibility depends on the match between the protocol and the individual case.
Clarify which tests and treatments are part of standard care and which are required only because of the research. Ask about known risks, possible benefits, unknowns, additional visits, travel, time commitment, and whether there is a comparison or control group.
Ask which costs the study covers, which may be billed to the patient or insurer, and who can answer financial questions. Learn the role of the institutional review board, how adverse events are monitored, whom to contact after hours, and what happens if a participant withdraws.
Burzynski Clinic reviews medical records before an initial consultation is scheduled. The clinic's prospective patient process lists the records recommended for evaluation and explains how patients may provide records or authorize the clinic to request them. Initial consultations take place in person at the Houston clinic.
Burzynski Clinic is located at 9432 Katy Freeway, Houston, Texas 77055. Stanislaw R. Burzynski, MD, PhD, Founder. Explore the clinic's published research or call 1-713-335-5697 for United States and international inquiries.